FCGR3A and COVID-19: The presence of activated CD16+ T cells and plasma concentrations of complement proteins preceding C3a were linked to lethal COVID-19 outcomes, underscoring the pathological significance of heightened cytotoxicity and complement activation in COVID-19 [22].